These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2199953)

  • 61. The diagnosis and treatment of impotence. Impotence Study Group of Western Australia.
    Med J Aust; 1988 May; 148(10):494-8. PubMed ID: 3367817
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Measuring nocturnal tumescence--value in diagnosis of impotence].
    Suter S; John H
    Ther Umsch; 1998 Jun; 55(6):361-4. PubMed ID: 9658977
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 64. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of treatment of impotence--where are we going?
    Lue TF
    West J Med; 1985 Apr; 142(4):546. PubMed ID: 4013267
    [No Abstract]   [Full Text] [Related]  

  • 66. [Diabetic impotence].
    Ishii N; Shirai M
    Nihon Rinsho; 1991 Feb; 49 Suppl():248-55. PubMed ID: 2033813
    [No Abstract]   [Full Text] [Related]  

  • 67. Summaries for patients. Hormonal testing and pharmacologic treatment of erectile dysfunction.
    Ann Intern Med; 2009 Nov; 151(9):I-44. PubMed ID: 19884619
    [No Abstract]   [Full Text] [Related]  

  • 68. Evaluation of the first 70 patients in the center for male sexual dysfunction of Beth Israel Medical Center.
    Melman A; Kaplan D; Redfield J
    J Urol; 1984 Jan; 131(1):53-5. PubMed ID: 6690747
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An intermediate approach to impotence evaluation.
    Melman A
    Contemp Urol; 1995 Jul; 7(7):14-8, 21. PubMed ID: 10150576
    [No Abstract]   [Full Text] [Related]  

  • 70. [Trial of intracavernous papaverine in the treatment of impotence. Therapeutic prospects].
    Virag R; Virag H
    J Mal Vasc; 1983; 8(4):293-5. PubMed ID: 6663198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The value of using a facilitating dose of papaverine chlorhydrate during cavernometry].
    Amer M; Lorge F; Schouman M; Arvis G
    Ann Urol (Paris); 1991; 25(1):25-9. PubMed ID: 2021270
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Erectile impotence: evaluation and management.
    Heller JE; Gleich P
    J Fam Pract; 1988 Mar; 26(3):321-4. PubMed ID: 3279158
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction.
    Levine LA; Lenting EL
    Urol Clin North Am; 1995 Nov; 22(4):775-88. PubMed ID: 7483128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Usefulness of the neuroandrologic profile study in patients with erectile dysfunction: review of a series of 180 cases].
    Salinas Casado J; Vírseda Chamorro M; Samblas García R; Esteban Fuertes M; Aristizábal Agudelo JM; Blázquez Izquierdo J; Delgado Martín JA; Resel Estévez L
    Arch Esp Urol; 1996 Oct; 49(8):849-57. PubMed ID: 9065283
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence.
    Kim SC; Oh MM
    J Urol; 1992 Jun; 147(6):1530-2. PubMed ID: 1593682
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 77. Organic impotence.
    Lue TF
    Curr Ther Endocrinol Metab; 1994; 5():329-33. PubMed ID: 7704747
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
    Rodriguez Antolin A; Morales JM; Andrés A; Fernández Aparicio T; Díaz González R; Pamplona M; Alvarez E
    Transplant Proc; 1992 Feb; 24(1):105-6. PubMed ID: 1539195
    [No Abstract]   [Full Text] [Related]  

  • 79. [Impotence. Diagnostic orientation].
    Virag R
    Rev Prat; 1991 May; 41(15):1399-402. PubMed ID: 2063142
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of I-C papaverine in patients with psychogenic and organic impotence.
    Cooper AJ
    Can J Psychiatry; 1991 Oct; 36(8):574-8. PubMed ID: 1742710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.